Multiplex CRISPR/Cas9-Based Genome Editing in Human Hematopoietic Stem Cells Models Clonal Hematopoiesis and Myeloid Neoplasia

Related Experiment Video

Updated: Jun 12, 2025

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
08:14

Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

Published on: October 3, 2019

12.1K

Zuzana Tothova, John M Krill-Burger, Katerina D Popova

    Cell Stem Cell
    |September 25, 2024
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
    12:04

    Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

    Published on: March 10, 2023

    3.5K
    Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9
    08:27

    Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9

    Published on: April 10, 2018

    13.4K

    Related Experiment Videos

    Last Updated: Jun 12, 2025

    Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
    08:14

    Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models

    Published on: October 3, 2019

    12.1K
    Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells
    12:04

    Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

    Published on: March 10, 2023

    3.5K
    Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9
    08:27

    Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9

    Published on: April 10, 2018

    13.4K

    Related Concept Videos

    CRISPR01:59

    CRISPR

    49.8K
    Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
    49.8K

    Articles linked to this work by shared authors, journal, and citation graph.

    DCAF11-dependent molecular glue degrader activated by glutathionylation.

    Nature·2026

    MRD dynamics predicts progression and reveals a vulnerable state for immunotherapy interception in multiple myeloma.

    Blood·2026

    A Type II CDK6 Degrader Enables Cellular Targeting beyond the Limits of Type II Inhibition.

    Journal of the American Chemical Society·2026

    Ppm1d Clonal Hematopoiesis Does Not Promote Atherosclerosis in Murine Models.

    Arteriosclerosis, thrombosis, and vascular biology·2026

    Ikaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies.

    Blood·2026

    Clonal hematopoiesis in lung adenocarcinoma pathogenesis.

    JCI insight·2026

    Electroconductive patch promotes heart repair by directing epicardial cells toward endothelial fate.

    Cell stem cell·2026

    EPCR expression marks CD150neg deeply dormant long-term hematopoietic stem cells.

    Cell stem cell·2026

    Organoids and organs-on-a-chip as new approach methodologies at the convergence of cell biology and bioengineering.

    Cell stem cell·2026

    Programmable apoptosis circuits enable subtractive engineering of stem cell-derived organoids and embryoids.

    Cell stem cell·2026

    Phase separation of Rbpms sequesters translation elongation machinery to preserve hematopoietic stem cell function.

    Cell stem cell·2026

    A self-organized tri-lineage bone model in liquefied microcapsules captures matrix dynamics in early remodeling.

    Cell stem cell·2026

    Cardiac adverse event signals of Bruton's tyrosine kinase inhibitors as primary suspect and in co-reported regimens: a large-scale FAERS pharmacovigilance study.

    Frontiers in pharmacology·2026

    Can we better evaluate responses in higher-risk myelodysplastic syndromes?

    Haematologica·2026

    Dynamics and clinical significance of coagulation abnormalities following CAR T-cell therapy.

    Haematologica·2026

    NEDD4 Promotes Hepatocellular Carcinoma Progression Through Ubiquitin-Dependent Degradation of EPHB6.

    Cancer science·2026

    Patients' preferences for accepting risks and uncertainty in AML treatments within European public health care systems: a cross-sectional study in Finland, Italy, and Germany.

    Leukemia & lymphoma·2026

    WNT5A-Associated Osteogenic Enhancement Contributes to the Protective Effects of OPG-Fc in Glucocorticoid-Associated Femoral Head Osteonecrosis.

    Biomolecules & therapeutics·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us